129 related articles for article (PubMed ID: 16395683)
21. Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience.
Vokurka S; Koza V; Jungova A; Navratilova J; Svoboda T; Jindra P; Steinerova K; Vyrutova R
Bone Marrow Transplant; 2012 Jun; 47(6):867-8. PubMed ID: 21874056
[No Abstract] [Full Text] [Related]
22. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
23. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
24. The effect of stem cell mobilisation with granulocyte colony-stimulating factor on the morphology of the haematopoietic organs in mice.
Barcew K; Paczkowska E; Dabkowska E; Baskiewicz-Masiuk M; Marchlewicz M; Domański L; Sagan L; Wiszniewska B; Machaliński B
Folia Morphol (Warsz); 2007 Feb; 66(1):1-9. PubMed ID: 17533587
[TBL] [Abstract][Full Text] [Related]
25. Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors.
Amariglio N; Jacob-Hirsch J; Shimoni A; Leiba M; Rechavi G; Nagler A
Acta Haematol; 2007; 117(2):68-73. PubMed ID: 17106189
[TBL] [Abstract][Full Text] [Related]
26. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
[TBL] [Abstract][Full Text] [Related]
27. Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.
Nakasone H; Kanda Y; Ueda T; Matsumoto K; Shimizu N; Minami J; Sakai R; Hagihara M; Yokota A; Oshima K; Tsukada Y; Tachibana T; Nakaseko C; Fujisawa S; Yano S; Fujita H; Takahashi S; Kanamori H; Okamoto S;
Am J Hematol; 2009 Dec; 84(12):809-14. PubMed ID: 19862826
[TBL] [Abstract][Full Text] [Related]
28. Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial.
Zohlnhöfer D; Kastrati A; Schömig A
Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S106-9. PubMed ID: 17230206
[TBL] [Abstract][Full Text] [Related]
29. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
[TBL] [Abstract][Full Text] [Related]
30. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
[TBL] [Abstract][Full Text] [Related]
31. Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF.
de Kruijf EJ; van Pel M; Hagoort H; Kruysdijk D; Molineux G; Willemze R; Fibbe WE
Hum Immunol; 2007 May; 68(5):368-74. PubMed ID: 17462504
[TBL] [Abstract][Full Text] [Related]
32. Severe autoimmune hyperthyroidism after donation of growth factor-primed allogeneic peripheral blood progenitor cells.
Kroschinsky F; Hundertmark J; Mauersberger S; Hermes M; Poppe-Thiede K; Rutt C; Ehninger G; Schuster P
Haematologica; 2004 Apr; 89(4):ECR05. PubMed ID: 15075097
[No Abstract] [Full Text] [Related]
33. Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion.
Chang SA; Kang HJ; Lee HY; Kim KH; Hur J; Han KS; Park YB; Kim HS
Heart; 2009 Aug; 95(16):1326-30. PubMed ID: 19460773
[TBL] [Abstract][Full Text] [Related]
34. [The role of stromal cell-derived factor and its receptor-CXCR4 in G-CSF-induced hematopoietic stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):98-102. PubMed ID: 17650669
[TBL] [Abstract][Full Text] [Related]
35. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
Abraham M; Biyder K; Begin M; Wald H; Weiss ID; Galun E; Nagler A; Peled A
Stem Cells; 2007 Sep; 25(9):2158-66. PubMed ID: 17525235
[TBL] [Abstract][Full Text] [Related]
36. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.
Huang XJ; Chang YJ; Zhao XY
Transpl Immunol; 2007 Apr; 17(3):193-7. PubMed ID: 17331846
[TBL] [Abstract][Full Text] [Related]
37. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
38. Medical and ethical considerations on hematopoietic stem cells mobilization for healthy donors.
Moalic-Allain V
Transfus Clin Biol; 2018 May; 25(2):136-143. PubMed ID: 29555414
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial.
Ripa RS; Haack-Sørensen M; Wang Y; Jørgensen E; Mortensen S; Bindslev L; Friis T; Kastrup J
Circulation; 2007 Sep; 116(11 Suppl):I24-30. PubMed ID: 17846310
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms that regulate homing function of progenitor cells in myocardial infarction.
Schlüter KD; Maxeiner H; Wenzel S
Minerva Cardioangiol; 2009 Apr; 57(2):203-17. PubMed ID: 19274030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
